Who Knew? Pharmaceutical-Biotech Industry Planning 200 New North American Sites with $14.4 Billion Investment
Who Knew? Pharmaceutical-Biotech Industry Planning 200 New North American Sites with $14.4 Billion Investment
Attachment: IIR Table - Active Pharma-Biotech Construction Projects in North America
SUGAR LAND--September 17, 2010--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--As the third quarter winds to an end and there are no definitive answers as to when the roller coaster ride of the Pharmaceutical-Biotech Industry will finally hit a steady rail up, it is a good time to look at new-build activity. For such an uncertain time, there certainly is a lot of construction. Within North America alone, the industry has 200 sites being actively developed. All are in various stages, from early planning to construction, and represent a potential $14.4 billion in capital investment, according to Industrial Info's Pharmaceutical Tracker - Online Database. Translating to a site average total investment value (TIV) of $72 million, the numbers underscore why life science projects remain at the top of any economic developer's "get" list.
Other companies featured: Shire plc's (NASDAQ:SHPGY), Alexandria Real Estate Equities Incorporated (NYSE:ARE)
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- México registra inversiones por 2 mil millones de dólares en el sector farm...
- Mexico Registers US$2 Billion in Pharmaceutical Investments
- New England Sees $27 Billion in Projects Under Construction
- Pharma, Manufacturing Lead Indiana to $21.6 Billion of Projects Under Const...
- India Aims to Reduce Dependence on China for Pharma Market